MedTrace Logo

To Evaluate the Efficacy and Safety Aliviador Compared to Gelol in Patients With Contusions, Sprains, Trauma and Muscle Injury.

NCT01097798 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2010-04-16

No results posted yet for this study

Summary

Multicenter, randomized, double-blind trial, to evaluate the efficacy and safety Aliviador compared to Gelol in the relief of signs and symptoms in patients with contusions, sprains, trauma and muscle injury start with less than 24 hours or patients of myalgia, myofascial pain and tendinitis.

Conditions

  • Contusions
  • Sprains
  • Trauma
  • Muscle Injury
  • Myalgia
  • Myofascial Pain
  • Tendinitis

Interventions

DRUG

Aliviador

The study medication should be applied regimen of 8/8 hours over 2 days.

DRUG

Gelol

The study medication should be applied regimen of 8/8 hours over 2 days.

Sponsors & Collaborators

  • Laboratorio Brasileiro de Biologia

    lead OTHER

Principal Investigators

  • Abel Pereira Junior, investigator · Faculdade de Medicina do ABC

  • Gilberto de Castro Brandão, investigator · Clínica Perdizes

  • Paulo Faria, investigator · S.C. Corinthians Paulista

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01097798 on ClinicalTrials.gov